ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
June 25 2024 - 7:00AM
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today
announced that its Chief Executive Officer, Nikhil Lalwani, has
been named an Ernst & Young LLP (EY US) Entrepreneur Of The
Year® 2024 New Jersey Award winner. Entrepreneur Of The Year is the
preeminent competitive awards program for entrepreneurs and leaders
of high-growth companies.
Mr. Lalwani was selected by an independent judging panel made up
of previous award winners, leading CEOs, and other business
leaders. Candidates were evaluated based on their ability to create
long-term value through entrepreneurial spirit, commitment to their
purpose, and the demonstration of growth and substantial impact,
among other key indicators.
Nikhil Lalwani, President and CEO of ANI, stated, “I am deeply
humbled and honored to receive this prestigious award on behalf of
the entire ANI Pharmaceuticals team. We remain steadfastly
committed to our purpose: Serving Patients, Improving Lives. In
parallel, we have achieved strong financial results, increasing our
Enterprise Value approximately 2.8X since September 2020, when I
joined as CEO. Each ANI team member and our Board has played an
important role in driving our success. I share this honor with them
and our customers, suppliers, partners, and shareholders whose
support we count on and are so grateful for.”
As a New Jersey award winner, Mr. Lalwani is now eligible for
consideration for the Entrepreneur Of The Year 2024 National Awards
and for the World Entrepreneur Of The Year® Award in June 2025.
The Entrepreneur Of The Year program has recognized the
leadership of entrepreneurs such as:
- Howard Schultz of Starbucks Coffee Company
- James Park of Fitbit
- Jodi Berg of Vitamix
- Hamdi Ulukaya of Chobani, Inc.
- Reid Hoffman and Jeff Weiner of LinkedIn Corporation
- Sheila Mikhail of AskBio
- Michael Happe of Winnebago Industries
Entrepreneur Of the Year recognizes many different types of
business leaders for their ingenuity, courage, and entrepreneurial
spirit. The program celebrates original founders who bootstrapped
their business from inception or who raised outside capital to grow
their company; transformational CEOs who infused innovation into an
existing organization to catapult its trajectory; and
multigenerational family business leaders who reimagined a legacy
business model to fortify it for the future.
In addition to Entrepreneur Of The Year, EY US supports other
entrepreneurs through the EY Entrepreneurial Winning
Women™ (Winning Women) program and the EY
Entrepreneurs Access Network (EAN) to help connect
women founders and Black and Hispanic/Latino entrepreneurs,
respectively, with the resources, network and access needed to
unlock their full potential.
SponsorsFounded and produced by Ernst &
Young LLP, the Entrepreneur Of The Year Awards include presenting
sponsors PNC Bank, Cresa, Marsh USA, SAP, and the Ewing Marion
Kauffman Foundation. In New Jersey, sponsors also include DLA Piper
and Empire Valuation Consultants.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high-quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. The Company is focused on delivering
sustainable growth by scaling up its Rare Disease business through
its lead asset Purified Cortrophin® Gel, strengthening its Generics
business with enhanced research and development capabilities,
delivering innovation in Established Brands, and leveraging its
U.S. based manufacturing footprint. For more information, please
visit our website www.anipharmaceuticals.com.
Investor Relations:Lisa M. Wilson, In-Site
Communications, Inc.T: 212-452-2793E: lwilson@insitecony.com
Media Contact:Faith Pomeroy-WardT:
817-807-8044E: faith.pomeroyward@anipharmaceuticals.com
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From May 2024 to Jun 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Jun 2023 to Jun 2024